Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 53

1.

Comparison of Gene Expression Profiles of Uropathogenic Escherichia Coli CFT073 after Prolonged Exposure to Subinhibitory Concentrations of Different Biocides.

Ligowska-Marzęta M, Hancock V, Ingmer H, M Aarestrup F.

Antibiotics (Basel). 2019 Sep 27;8(4). pii: E167. doi: 10.3390/antibiotics8040167.

2.

Investigation of the quality of stored red blood cells after simulated air drop in the maritime environment.

Meli A, Hancock V, Doughty H, Smedley S, Cardigan R, Wiltshire M.

Transfusion. 2018 Feb;58(2):423-429. doi: 10.1111/trf.14403. Epub 2017 Nov 27.

PMID:
29193159
3.

Low concentrations of citrate reduce complement and granulocyte activation in vitro in human blood.

Huang S, Sandholm K, Jonsson N, Nilsson A, Wieslander A, Grundström G, Hancock V, Ekdahl KN.

Clin Kidney J. 2015 Feb;8(1):31-7. doi: 10.1093/ckj/sfu127. Epub 2014 Dec 1.

4.

Molecular analysis of asymptomatic bacteriuria Escherichia coli strain VR50 reveals adaptation to the urinary tract by gene acquisition.

Beatson SA, Ben Zakour NL, Totsika M, Forde BM, Watts RE, Mabbett AN, Szubert JM, Sarkar S, Phan MD, Peters KM, Petty NK, Alikhan NF, Sullivan MJ, Gawthorne JA, Stanton-Cook M, Nhu NT, Chong TM, Yin WF, Chan KG, Hancock V, Ussery DW, Ulett GC, Schembri MA.

Infect Immun. 2015 May;83(5):1749-64. doi: 10.1128/IAI.02810-14. Epub 2015 Feb 9.

5.

The 30 minute rule for red blood cells: in vitro quality assessment after repeated exposure to 30°C.

Thomas S, Hancock V, Cardigan R.

Transfusion. 2013 Jun;53(6):1169-77. doi: 10.1111/j.1537-2995.2012.03890.x. Epub 2012 Sep 21.

PMID:
22995049
6.

Identification of genes important for growth of asymptomatic bacteriuria Escherichia coli in urine.

Vejborg RM, de Evgrafov MR, Phan MD, Totsika M, Schembri MA, Hancock V.

Infect Immun. 2012 Sep;80(9):3179-88. doi: 10.1128/IAI.00473-12. Epub 2012 Jul 2.

7.

Repeated short-term warming of red blood cell concentrates has minimal effect on their quality.

Thomas S, Hancock V, Cardigan R.

Vox Sang. 2012 Aug;103(2):113-21. doi: 10.1111/j.1423-0410.2012.01589.x. Epub 2012 Mar 10.

PMID:
22404883
8.

Intramacrophage survival of uropathogenic Escherichia coli: differences between diverse clinical isolates and between mouse and human macrophages.

Bokil NJ, Totsika M, Carey AJ, Stacey KJ, Hancock V, Saunders BM, Ravasi T, Ulett GC, Schembri MA, Sweet MJ.

Immunobiology. 2011 Nov;216(11):1164-71. doi: 10.1016/j.imbio.2011.05.011. Epub 2011 May 24.

PMID:
21802164
9.

Red cell concentrate storage and transport temperature.

Hancock V, Cardigan R, Thomas S.

Transfus Med. 2011 Oct;21(5):325-9. doi: 10.1111/j.1365-3148.2011.01083.x. Epub 2011 Jun 26.

PMID:
21707796
10.

Comparative genomics of Escherichia coli isolated from patients with inflammatory bowel disease.

Vejborg RM, Hancock V, Petersen AM, Krogfelt KA, Klemm P.

BMC Genomics. 2011 Jun 15;12:316. doi: 10.1186/1471-2164-12-316.

11.

Biofilm formation as a function of adhesin, growth medium, substratum and strain type.

Hancock V, Witsø IL, Klemm P.

Int J Med Microbiol. 2011 Nov;301(7):570-6. doi: 10.1016/j.ijmm.2011.04.018. Epub 2011 Jun 6.

PMID:
21646046
12.

Comparative genomics of Escherichia coli strains causing urinary tract infections.

Vejborg RM, Hancock V, Schembri MA, Klemm P.

Appl Environ Microbiol. 2011 May;77(10):3268-78. doi: 10.1128/AEM.02970-10. Epub 2011 Mar 18.

13.

Core temperature changes in red blood cells.

Thomas S, Wiltshire M, Hancock V, Fletcher S, McDonald C, Cardigan R.

Transfusion. 2011 Feb;51(2):442-3. doi: 10.1111/j.1537-2995.2010.02927.x. No abstract available.

PMID:
21309781
14.

Functional genomics of probiotic Escherichia coli Nissle 1917 and 83972, and UPEC strain CFT073: comparison of transcriptomes, growth and biofilm formation.

Hancock V, Vejborg RM, Klemm P.

Mol Genet Genomics. 2010 Dec;284(6):437-54. doi: 10.1007/s00438-010-0578-8. Epub 2010 Oct 1.

PMID:
20886356
15.

Fimbrial adhesins from extraintestinal Escherichia coli.

Klemm P, Hancock V, Schembri MA.

Environ Microbiol Rep. 2010 Oct;2(5):628-40. doi: 10.1111/j.1758-2229.2010.00166.x.

PMID:
23766248
16.

Platelet apoptosis and activation in platelet concentrates stored for up to 12 days in plasma or additive solution.

Cookson P, Sutherland J, Turner C, Bashir S, Wiltshire M, Hancock V, Smith K, Cardigan R.

Transfus Med. 2010 Dec;20(6):392-402. doi: 10.1111/j.1365-3148.2010.01034.x. Epub 2010 Aug 26.

PMID:
20738829
17.

Prevention of bacterial adhesion.

Klemm P, Vejborg RM, Hancock V.

Appl Microbiol Biotechnol. 2010 Sep;88(2):451-9. doi: 10.1007/s00253-010-2805-y. Epub 2010 Aug 8. Review.

PMID:
20694794
18.

Escherichia coli isolates causing asymptomatic bacteriuria in catheterized and noncatheterized individuals possess similar virulence properties.

Watts RE, Hancock V, Ong CL, Vejborg RM, Mabbett AN, Totsika M, Looke DF, Nimmo GR, Klemm P, Schembri MA.

J Clin Microbiol. 2010 Jul;48(7):2449-58. doi: 10.1128/JCM.01611-09. Epub 2010 May 5.

19.

Abolition of biofilm formation in urinary tract Escherichia coli and Klebsiella isolates by metal interference through competition for fur.

Hancock V, Dahl M, Klemm P.

Appl Environ Microbiol. 2010 Jun;76(12):3836-41. doi: 10.1128/AEM.00241-10. Epub 2010 Apr 23.

20.

A virulent parent with probiotic progeny: comparative genomics of Escherichia coli strains CFT073, Nissle 1917 and ABU 83972.

Vejborg RM, Friis C, Hancock V, Schembri MA, Klemm P.

Mol Genet Genomics. 2010 May;283(5):469-84. doi: 10.1007/s00438-010-0532-9. Epub 2010 Mar 31.

PMID:
20354866
21.

Probiotic Escherichia coli strain Nissle 1917 outcompetes intestinal pathogens during biofilm formation.

Hancock V, Dahl M, Klemm P.

J Med Microbiol. 2010 Apr;59(Pt 4):392-9. doi: 10.1099/jmm.0.008672-0. Epub 2010 Jan 28.

PMID:
20110388
22.

Dietary plant components ellagic acid and tannic acid inhibit Escherichia coli biofilm formation.

Hancock V, Dahl M, Vejborg RM, Klemm P.

J Med Microbiol. 2010 Apr;59(Pt 4):496-8. doi: 10.1099/jmm.0.013680-0. Epub 2009 Dec 3. No abstract available.

PMID:
19959627
23.

Comparative analysis of antibiotic resistance and phylogenetic group patterns in human and porcine urinary tract infectious Escherichia coli.

Hancock V, Nielsen EM, Krag L, Engberg J, Klemm P.

APMIS. 2009 Nov;117(11):786-90. doi: 10.1111/j.1600-0463.2009.02542.x.

PMID:
19845528
24.

Inactivation of efflux pumps abolishes bacterial biofilm formation.

Kvist M, Hancock V, Klemm P.

Appl Environ Microbiol. 2008 Dec;74(23):7376-82. doi: 10.1128/AEM.01310-08. Epub 2008 Oct 3.

25.

Genotypic and phenotypic characterisation of Escherichia coli strains associated with porcine pyelonephritis.

Krag L, Hancock V, Aalbaek B, Klemm P.

Vet Microbiol. 2009 Mar 2;134(3-4):318-26. doi: 10.1016/j.vetmic.2008.08.025. Epub 2008 Aug 29.

PMID:
18835113
26.

Transcriptomics and adaptive genomics of the asymptomatic bacteriuria Escherichia coli strain 83972.

Hancock V, Seshasayee AS, Ussery DW, Luscombe NM, Klemm P.

Mol Genet Genomics. 2008 May;279(5):523-34. doi: 10.1007/s00438-008-0330-9.

27.

The ferric yersiniabactin uptake receptor FyuA is required for efficient biofilm formation by urinary tract infectious Escherichia coli in human urine.

Hancock V, Ferrières L, Klemm P.

Microbiology. 2008 Jan;154(Pt 1):167-75. doi: 10.1099/mic.0.2007/011981-0.

PMID:
18174135
28.

Candidate targets for new antivirulence drugs: selected cases of bacterial adhesion and biofilm formation.

Klemm P, Hancock V, Kvist M, Schembri MA.

Future Microbiol. 2007 Dec;2(6):643-53.

PMID:
18041905
29.

In vitro function of buffy coat-derived platelet concentrates stored for 9 days in CompoSol, PASII or 100% plasma in three different storage bags.

Cardigan R, Sutherland J, Garwood M, Bashir S, Turner C, Smith K, Hancock V, Wiltshire M, Pergande C, Williamson LM.

Vox Sang. 2008 Feb;94(2):103-12. Epub 2007 Nov 22.

PMID:
18034786
30.

Specific selection for virulent urinary tract infectious Escherichia coli strains during catheter-associated biofilm formation.

Ferrières L, Hancock V, Klemm P.

FEMS Immunol Med Microbiol. 2007 Oct;51(1):212-9. Epub 2007 Jul 23.

31.

Biofilm exclusion of uropathogenic bacteria by selected asymptomatic bacteriuria Escherichia coli strains.

Ferrières L, Hancock V, Klemm P.

Microbiology. 2007 Jun;153(Pt 6):1711-9.

PMID:
17526829
32.

Mellowing out: adaptation to commensalism by Escherichia coli asymptomatic bacteriuria strain 83972.

Klemm P, Hancock V, Schembri MA.

Infect Immun. 2007 Aug;75(8):3688-95. Epub 2007 May 14. Review. No abstract available.

33.

Biofilm formation by asymptomatic and virulent urinary tract infectious Escherichia coli strains.

Hancock V, Ferrières L, Klemm P.

FEMS Microbiol Lett. 2007 Feb;267(1):30-7. Epub 2006 Dec 8.

34.
35.

Porphyria cutanea tarda: the etiological importance of mutations in the HFE gene and viral infection is population-dependent.

Hift RJ, Corrigall AV, Hancock V, Kannemeyer J, Kirsch RE, Meissner PN.

Cell Mol Biol (Noisy-le-grand). 2002 Dec;48(8):853-9.

PMID:
12699243
36.

Identification of the first variegate porphyria mutation in an indigenous black South African and further evidence for heterogeneity in variegate porphyria.

Corrigall AV, Hift RJ, Davids LM, Hancock V, Meissner D, Kirsch RE, Meissner PN.

Mol Genet Metab. 2001 May;73(1):91-6.

PMID:
11350188
37.

Homozygous variegate porphyria in South Africa: genotypic analysis in two cases.

Corrigall AV, Hift RJ, Davids LM, Hancock V, Meissner D, Kirsch RE, Meissner PN.

Mol Genet Metab. 2000 Apr;69(4):323-30.

PMID:
10870850
38.

Identification and characterisation of a deletion (537delAT) in the protoporphyrinogen oxidase gene in a South African variegate porphyria family.

Corrigall AV, Hift RJ, Hancock V, Meissner D, Davids L, Kirsch RE, Meissner PN.

Hum Mutat. 1998;12(6):403-7.

PMID:
9829909
39.

The expression of mRNA for fibrinogen in megakaryocytes isolated from patients with T-cell lymphoma.

Podolak-Dawidziak M, Hancock V, Lelchuk R, Kotlarek-Haus S, Martin JF.

Br J Haematol. 1995 Oct;91(2):362-6.

PMID:
8547076
40.

Megakaryocytes from patients with coronary atherosclerosis express the inducible nitric oxide synthase.

de Belder A, Radomski M, Hancock V, Brown A, Moncada S, Martin J.

Arterioscler Thromb Vasc Biol. 1995 May;15(5):637-41.

PMID:
7538428
41.

The relationship between human megakaryocyte nuclear DNA content and gene expression.

Hancock V, Martin JF, Lelchuk R.

Br J Haematol. 1993 Dec;85(4):692-7.

PMID:
7918031
42.

Antimicrotubule agents induce polyploidization of human leukaemic cell lines with megakaryocytic features.

van der Loo B, Hong Y, Hancock V, Martin JF, Erusalimsky JD.

Eur J Clin Invest. 1993 Oct;23(10):621-9.

PMID:
7904241
43.

Analysis of the dynamics of Pneumocystis carinii in vitro.

Jackson HC, Hancock V, Elahi N.

J Protozool. 1991 Nov-Dec;38(6):93S-95S.

PMID:
1818222
44.

Ultrastructural observations on the attachment of Pneumocystis carinii in vitro.

Dei-Cas E, Jackson H, Palluault F, Aliouat EM, Hancock V, Soulez B, Camus D.

J Protozool. 1991 Nov-Dec;38(6):205S-207S.

PMID:
1818171
45.

Exploitation of a 650 bp probe for quantification of Pneumocystis carinii.

Hancock V, Christodoulou C, Jackson HC.

J Protozool. 1991 Nov-Dec;38(6):200S-202S.

PMID:
1818169
46.

No detection of characteristic fungal protein elongation factor EF-3 in Pneumocystis carinii.

Jackson HC, Colthurst D, Hancock V, Marriott MS, Tuite MF.

J Infect Dis. 1991 Mar;163(3):675-7.

PMID:
1995744
47.

Identification of mRNA for PDGF B-chain in human megakaryocytes isolated using a novel immunomagnetic separation method.

Gladwin AM, Carrier MJ, Beesley JE, Lelchuk R, Hancock V, Martin JF.

Br J Haematol. 1990 Nov;76(3):333-9.

PMID:
2261343
48.

The relationship between megakaryocyte nuclear DNA content and gene expression.

Lelchuk R, Carrier M, Hancock V, Martin JF.

Int J Cell Cloning. 1990 Jul;8(4):277-82.

PMID:
2401805
49.
50.

Women in Arizona medicine: Mary Lawson Neff, M.D. Part II.

Hancock V 3rd.

Ariz Med. 1984 Dec;41(12):819-21. No abstract available.

PMID:
6393919

Supplemental Content

Loading ...
Support Center